Abstract
Glutaric acidemia type 1 (GA1) is an inherited metabolic autosomal recessive disorder that is caused by a deficiency in glutaryl-CoA dehydrogenase (GCDH). Untreated patients suffer primarily from severe striatal damage. More than 250 variants in the GCDH gene have been reported with a variable frequency among different ethnic groups. In this study, we aimed to characterize 89 Egyptian patients with GA1 and identify the variants in the 41 patients who were available for genotyping. All of our patients demonstrated clinical, neuroradiological, and biochemical characteristics that are consistent with a diagnosis of GA1. All patients presented with variable degrees of developmental delay ranging from mild to severe. Most of the 89 patients presented with acute onset type (71.9%), followed by insidious (19%) and asymptomatic (9%). A delay in diagnosis was inversely associated with macrocephaly. The prevalence rate ratio (PR) for macrocephaly that was associated with each 6-month delay was 0.95 (95%CI 0.91–0.99). However, high body weight was associated with a higher likelihood of having macrocephaly (PR 1.16, 95%CI 1.06–1.26 per 1 SD increment of Z score weight). However, body weight was inversely associated with the morbidity score. Consanguinity level was 64% among our patient’s cohort and was positively associated with the C5DC level (β (95%CI) 1.06 (0.12–1.99)). Forty-one patients were available for genotyping and were sequenced for the GCDH gene. We identified a total of 25 variants, of which the following six novel variants were identified: three missense variants, c.320G > T (p.Gly107Val), c.481C > T (p.Arg161Trp) and c.572 T > G (p.Met191Arg); two deletions, c.78delG (p.Ala27Argfs34) and c.1035delG (p.Gly346Alafs*11); and one indel, c.272_331del (p.Val91_Lys111delinsGlu). All of the novel variants were absent in the 300 normal chromosomes. The most common variant, c.*165A > G, was detected in 42 alleles, and the most commonly detected missense variant, c.1204C > T (p.Arg402Trp), was identified in 29 mutated alleles in 15/41 (34.2%) of patients. Our findings suggest that GA1 is not uncommon organic acidemia disease in Egypt; therefore, there is a need for supporting neonatal screening programs in Egypt.
Highlights
Glutaric aciduria type 1 (GA1, MIM#231670) is an autosomal recessive inborn error of metabolism
The combined worldwide frequency of Glutaric acidemia type 1 (GA1) that was calculated from newborn screening of 2.5 million children using MS/MS is 1:100,000 infants (Lindner et al 2004)
The patients were diagnosed with GA1 based on their clinical presentation, neuroimaging and biochemical measurements, and molecular genetic analyses (41 patients) at the Genetics Unit, Ain Shams University Hospital (GUASH)
Summary
Glutaric aciduria type 1 (GA1, MIM#231670) is an autosomal recessive inborn error of metabolism. The combined worldwide frequency of GA1 that was calculated from newborn screening of 2.5 million children using MS/MS is 1:100,000 infants (Lindner et al 2004). This disease is caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase GCDH (Kolker et al 2006). The GCDH gene (NM_000159.3; 19p13.2) consists of 11 exons that span approximately 7-kb of genomic DNA (Biery et al 1996). GCDH is made as a precursor protein of 438 amino acids. After it is imported into the mitochondria, its 44 N-terminal amino acid residues are
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have